iTeos Therapeutics, Inc.

ITOS · NASDAQ
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Operating Activities
Net Income-$79-$35-$44-$45
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$6$7$7$8
Change in WC$33-$7$48$31
Other Non-Cash-$3$1-$7-$31
Operating Cash Flow-$42-$34$5-$37
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$30-$60-$80-$196
Inv. Sales/Matur.$117$108$94$104
Other Inv. Act.-$0-$0-$0$0
Investing Cash Flow$87$48$14-$91
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0-$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$4$0$0-$0
Financing Cash Flow$4$0$0-$0
Forex Effect$2$0-$1$2
Net Chg. in Cash$51$14$18-$127
Supplemental Information
Beg. Cash$157$142$124$251
End Cash$208$157$142$124
Free Cash Flow-$43-$34$5-$37